Share

South San Francisco’s KaloBios Fires Pharma CEO Martin Shkreli

KaloBios has announced that Martin Shkreli resigned from its board of directors and was removed from his approximately month-long tenure as the biotech’s CEO following his arrest last Thursday.

Advertisement


Platini Accuses FIFA Ethics Committee Of Witch-Hinting
Both are under scrutiny over a 2011 payment of two million Swiss francs ( million) made to Platini with Blatter’s approval, for work done 10 years earlier.

He’s been dubbed the internet’s most hated man and is now facing fraud charges, so we reckon it was just a matter of time before this happened.


Islamic State conflict: Iraqi forces ‘move into Ramadi’
This image shows a bridge destroyed by ISIS to block Iraqi security forces from moving forward on the Euphrates river in Ramadi. Iraqi troops are on a mission to retake Ramadi after losing the city in May. “We’re dealing with them with air force support”.

Shkreli, 32, who is free on $5 million bail, maintains that he is innocent and will be vindicated.


‘Today is a sad day’ – Azpilicueta reacts to Mourinho sacking
The charismatic former Barcelona manager is expected to announce he will quit Bayern Munich at the end of the season. So I think it’s very easy to make that kind of inference but it’s not one that the club accepts”.

THE under-fire hedge fund manager and entrepreneur Martin Shkreli has been fired from his role as CEO of a Californian pharmaceuticals company.

His arrest on securities fraud charges stem from Shkreli’s hedge fund, MSMB Capital Management, and Retrophin, another pharmaceutical company. The University of California-Davis also suspended a planned drug trial with the company after the arrest, Bloomberg reported. Its shares tumbled 70 percent in January after its drug for lung infections failed in testing. The company also said that the toxoplasmosis drug Daraprimp will continue to be available to providers and patients despite Shkreli’s indictment and ouster. (AP Photo/Craig Ruttle)Shkreli’s charged with losing investors’ money through bad trades – then taking $11 million from his former company to pay disgruntled clients.

“It was hacked”, Craig Stevens, a spokesman for the former CEO of Turing Pharmaceuticals, confirmed to Reuters.

A day later, his Twitter account, which now features the name “Martin the God”, got hacked.

Shkreli has refused to apologize for jacking up the price of Daraprim from $13.50 to $750 a dose, and told a drug conference that he would like to have raised the prices higher to please his investors. The company wouldn’t answer questions Monday about who will take control and when its shares will resume trading. The drug under testing known as KB003, is meant for use in the treatment of leukemia.

KaloBios also announced today that Tony Chase, who joined the board along with Shkreli back in November, has also resigned.

Advertisement

Shkreli, through his press relations firm, said he is confident he will be cleared of all charges, adding that some of the charges involved “complex accounting matters” that authorities failed to understand.

University of California at Davis and Moffitt Cancer Center in Florida